Can-Fite BioPharma Investor Relations Material
Latest events
C-level Sitdown
Can-Fite BioPharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Can-Fite BioPharma Ltd
Access all reports
Can-Fite BioPharma Ltd is an Israel-based clinical-stage biopharmaceutical company focused on developing oral small molecule drugs for the treatment of cancer, liver, and inflammatory diseases. The company’s drug candidates target the A3 adenosine receptor, which is highly expressed in pathological cells. Its pipeline includes treatments for conditions such as liver cancer, psoriasis, and osteoarthritis. Can-Fite conducts clinical trials and collaborates with international research institutions. The company is headquartered in Petah Tikva, Israel, and its shares are listed on the NYSE American.
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
CANF
Country
🇮🇱 Israel